Navigation Links
Global Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment Research Report
Date:7/23/2013

Albany, NY (PRWEB) July 24, 2013

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 261 tables & figures over 205 pages. The personalized medicine (global) market is presented as follows:

By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, decode /Amgen, CELERA, MYRIAD)
By Geography (US, UK, EU)
By Segment (Targeted Therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)
By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, Pharmacogenomics, consumer genomics)

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/personalized-medicine-and-companion-diagnostic-market-q2-2013-a-strategic-analysis-of-industry-trends-technologies-participants-and-environment

A wealth of financial data & business strategy information is provided including:

    Up-to-date company Financials, sales & revenue figures
    Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
    Business Model Strategies for Providers. Provider Systems and Academic Medical Centers
    Business Model Strategies for Payers & Governments
    Private and Public Funding and Personalized Medicine Reimbursement
    Revisions to Current Payment Systems and intellectual property
    How to Gain Market Penetration in the EU
    Cost-effectiveness and Business Value of Personalized Medicine
    Consumer genomics and POC market
    Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
    Comprehensive account of company product portfolios & kits

Browse All The Report Of This Publisher, Visit: http://www.marketresearchreports.biz/publisher/96

SWOT, Economic & Regulatory Environment specifics include:

    Key strengths, weaknesses and threats influencing leading player position within the market
    Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
    Top fastest growing market segments and emerging opportunities
    Top pharmaceutical companies within the IPM by market share and revenue
    Comprehensive product portfolios, R&D activity and pipeline therapeutics
    M&A activity and future strategies of top personalized medicine pharmacies
    Personalized Medicine Regulation (UK, Germany, France, Spain, Italy)
    CE-marked Personalized Medicine/Diagnostic Tests
    FDA Advances in Personalized Medicine Regulation

For more reports of this category, Visit - http://www.marketresearchreports.biz/category/38

This report highlights a number of significant Indian pharmacy and gives details of their operations, products, financial and business strategy.

    23andMe
    Affymetrix
    Astex Pharmaceuticals
    Atossa Genetics
    CuraGen
    Celera Corporation (Quest Diagnostics)
    Celldex Therapeutics
    Decode Genetics (Amgen)
    Illumine
    Genelex
    Myriad
    Nodality
    Qiagen

For Premium Market Research Reports, Visit - http://mresearchreports.blogspot.com/

What you will gain:

An in-depth understanding of the global personalized medicine market and its environment
Current market facts, figures and product lines of key players in the industry
Emerging trends in key markets such as the US, UK, Germany and France
Knowledge of how the personalized medicine market will integrate into the global healthcare market
Technical insights into a new generation sequencing technologies and ultra-high throughput sequencing
Updates on Bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies
FDA approved pharmacogenetic tests and recognized biomarkers
Information on key government and regulatory policies
Strategies on how to adapt and restructure current business models in this industry

This report tackles key concerns to the personalized medicine market such as:

    Lack of regulatory policy and legislation in the US and Europe
    Reimbursement schemes and payers concerns
    Transition of investigational diagnostic assays and therapeutics to clinical practice
    Direct to consumer (DTC) test kits and implications for the public

To Buy The Copy of This Report, Visit: http://www.marketresearchreports.biz/analysis/171740

Who should read this report?

Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
Industry professionals and business strategists will discover key information to propel their policies
Investors will gain inside information to dominant players in the industry and future forecasts
Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment

This report will tell you if the companies mentioned are:

    Strong, competitive players
    Pooling their resources for specific growth and therapeutic areas
    Investing strategically in R&D
    Have a history of strategic M&A activity

Contact US
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Website: http://www.marketresearchreports.biz/
Blog: http://mrrbiz.blogspot.com/    
Blog: http://marketsbuzz.wordpress.com/

Read the full story at http://www.prweb.com/releases/2013/Personalized-Medicine/prweb10954759.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Gianluca Tognon Announces a New E-book About the Consequences of Global Warming on Food Safety and Human Health
2. Radiofrequency Ablation Devices Market is Expected to Reach USD 1.0 Billion Globally in 2018: Transparency Market Research
3. Global Portable Oxygen Concentrators Market are Anticipated to Reach $1.9 billion by 2019 - Industry Shares, Strategies, and Forecasts, Worldwide Research Report
4. Health Affairs July issue contains global innovation studies from India And Brazil
5. Global Digital Pathology Market to Reach $336.6 Million by 2017 at a CAGR of 12% - New Report by MarketsandMarkets
6. Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent)
7. Global Ammunition Market Worth $8.15 Billion by 2017 at a CAGR of 0.67% - New Report by MarketsandMarkets
8. Global Magnetic Resonance Imaging System Market – MRI 2018 Forecast & Analysis in New Research Report at ReportsnReports.com
9. Global Catheters Market Will Reach USD 33.3 Billion in 2017: Transparency Market Research
10. Global Food Protection Institute to Exhibit at Institute of Food Technologists' Food Expo
11. j2 Global’s Annual Mid-Year Small Business Report Card: How SMBs Get Work Done
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... 22, 2017 , ... Egg freezing and embryo freezing are ... a slight statistical advantage for live births, frozen eggs offer many advantages, depending ... undergoing medical treatment or who are concerned about the decline of their fertility ...
(Date:9/21/2017)... ... September 21, 2017 , ... 38-Year-Old Plastic Surgeon Gill at Aesthetic Surgery ... is pleased to announce that Plastic Surgeon Kiranjeet Gill has been awarded as one ... is an annual award that was started in 2003 to salute young achievers in ...
(Date:9/21/2017)... ... September 21, 2017 , ... The American Addiction ... Services for professionals in the addiction treatment industry entitled: Special Investigations Unit ... Insurance companies and state and federal governments are increasingly scrutinizing the addiction treatment ...
(Date:9/21/2017)... ... 21, 2017 , ... Demonstrating a consistent and continued commitment ... been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million people, ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in Chicago, ... the life-sciences industry for ensuring label quality and improving patient safety. , ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... 5, 2017 Sapheneia and Scannerside received FDA ... DoseCheck is a third-party Vendor neutral CT product that ... allows compliance with current MITA standards. ... DoseCheck solution is specifically designed to provide CT operators, ... radiation doses over a predefined threshold. Scannerside Dose Check ...
(Date:9/1/2017)... PALMER, Mass. , Sept. 1, 2017 ... Complete HealthCare Solutions, Inc , highlights opportunities for growth ... Street Journal report that Marlin Equity is seeking a ... is an annual award-winning 22-year-old healthcare solutions Value Added ... market.  "As the ...
(Date:8/29/2017)... , Aug. 29, 2017 In a ... security, and regulatory compliance for veterinary practices of all ... a new partnership that makes TITAN,s expertise in physical ... available to Cubex,s clients nationally. ... buying and handling controlled substances is at risk today," ...
Breaking Medicine Technology: